ALKERMES | 资产



Assets 更改 日
AbbVie USD 135.16B 8.26B 2024-12
Acadia Pharmaceuticals USD 1.19B 210.89M 2024-12
ALKERMES USD 2.06B 99.72M 2024-12
Amgen USD 91.84B 956M 2024-12
Biogen USD 28.05B 263.9M 2024-12
BioMarin Pharmaceutical USD 6.99B 137.74M 2024-12
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Eli Lilly USD 78.71B 3.11B 2024-12
Gilead Sciences USD 56.43B 2.56B 2025-03
Ionis Pharmaceuticals USD 2.81B 190.73M 2025-03
J&J USD 180.1B 1.82B 2024-12
Malin Corporation EUR 128.4M 11.8M 2024-06
Merck USD 117.11B 426M 2024-12
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Otsuka Holdings JPY 3.69T 46.2B 2025-03
Pfizer USD 213.4B 6.08B 2024-12
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



ALKERMES 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.